- Home
- SCOR vs KALA Comparison
SCOR vs KALA Comparison
Compare SCOR & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCOR
- KALA
- Stock Information
- Founded
- SCOR 1999
- KALA 2009
- Country
- SCOR United States
- KALA United States
- Employees
- SCOR N/A
- KALA N/A
- Industry
- SCOR Business Services
- KALA Biotechnology: Pharmaceutical Preparations
- Sector
- SCOR Consumer Discretionary
- KALA Health Care
- Exchange
- SCOR Nasdaq
- KALA Nasdaq
- Market Cap
- SCOR 23.9M
- KALA 26.2M
- IPO Year
- SCOR 2007
- KALA 2017
- Fundamental
- Price
- SCOR $5.52
- KALA $5.87
- Analyst Decision
- SCOR Buy
- KALA Strong Buy
- Analyst Count
- SCOR 2
- KALA 3
- Target Price
- SCOR $10.75
- KALA $14.00
- AVG Volume (30 Days)
- SCOR 22.7K
- KALA 125.3K
- Earning Date
- SCOR 08-05-2025
- KALA 08-05-2025
- Dividend Yield
- SCOR N/A
- KALA N/A
- EPS Growth
- SCOR N/A
- KALA N/A
- EPS
- SCOR N/A
- KALA N/A
- Revenue
- SCOR $354,961,000.00
- KALA N/A
- Revenue This Year
- SCOR $3.36
- KALA N/A
- Revenue Next Year
- SCOR $2.72
- KALA N/A
- P/E Ratio
- SCOR N/A
- KALA N/A
- Revenue Growth
- SCOR N/A
- KALA N/A
- 52 Week Low
- SCOR $4.39
- KALA $2.92
- 52 Week High
- SCOR $15.31
- KALA $11.20
- Technical
- Relative Strength Index (RSI)
- SCOR 59.22
- KALA 60.68
- Support Level
- SCOR $4.39
- KALA $4.36
- Resistance Level
- SCOR $5.93
- KALA $7.00
- Average True Range (ATR)
- SCOR 0.32
- KALA 0.71
- MACD
- SCOR 0.08
- KALA 0.16
- Stochastic Oscillator
- SCOR 63.06
- KALA 63.97
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.